Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Sarepta Therapeutics, Inc. (NASDAQ: SRPT)
SRPT Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-15.50%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
35%
SRPT Stock Analysis
SRPT
PE Ratio:
77.3
SRPT
PEG Ratio:
Not Available
SRPT
Forward EPS Growth (12 month):
0.00%
SRPT
PS Ratio:
0.8
SRPT
PSG Ratio:
Not Available
SRPT
Forward Revenue Growth (12 month):
0.00%
SRPT Articles
No data was found